NCT03595813
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Institut Paoli-Calmettes Marseille, Bouches-du-Rhône, France
Clinical trial condition
Urologic Neoplasms
Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.
105 public trials
26 recruiting studies
Urologic Neoplasms trial results
NCT07305142
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Completed
Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
NCT02276924
- Conditions
- Cancer of Urinary Tract, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Groupement des Hôpitaux de l'Institut Catholique de Lille Lille, Hauts-de-France, France
NCT06545188
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
- Locations
-
- University Hospital Düsseldorf, Department of Urology Düsseldorf, Germany
NCT03081858
- Conditions
- Bladder Cancer, Bladder Cancer Cell Transitional, Carcinoma, +17 more
- Locations
-
- Urological Associates of Southern Arizona, PC Tucson, Arizona, United States
- Trovare Clinical Research Bakersfield, California, United States
- Tower Urology Los Angeles, California, United States
- Chesapeake Urology Associates Hanover, Maryland, United States
NCT02836795
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +17 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
NCT02783300
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +38 more
- Locations
-
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site New York, United States
- GSK Investigational Site Nashville, Tennessee, United States
Completed
Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer
NCT03473730
- Conditions
- Adenocarcinoma, Bladder Urothelial Carcinoma, Carcinoma, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT06452212
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +7 more
- Locations
-
- KR82001 Seoul, South Korea
NCT04005183
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada